S&P 500   0.56 (+5.04%)
DOW   0.56 (+5.04%)
QQQ   269.38 (+1.35%)
AAPL   435.75 (+2.52%)
MSFT   216.54 (+5.62%)
FB   251.96 (-0.67%)
GOOGL   1,482.76 (-0.35%)
AMZN   3,111.89 (-1.67%)
NVDA   440.41 (+3.73%)
CGC   19.06 (+4.27%)
BABA   257.94 (+2.76%)
TSLA   1,485.00 (+3.79%)
MU   50.39 (+0.68%)
GE   6.11 (+0.66%)
AMD   77.67 (+0.31%)
T   29.62 (+0.14%)
F   6.69 (+1.21%)
ACB   10.42 (+2.26%)
GILD   71.73 (+3.16%)
NFLX   498.62 (+1.99%)
DIS   116.35 (-0.50%)
BAC   24.99 (+0.44%)
BA   162.27 (+2.70%)
S&P 500   0.56 (+5.04%)
DOW   0.56 (+5.04%)
QQQ   269.38 (+1.35%)
AAPL   435.75 (+2.52%)
MSFT   216.54 (+5.62%)
FB   251.96 (-0.67%)
GOOGL   1,482.76 (-0.35%)
AMZN   3,111.89 (-1.67%)
NVDA   440.41 (+3.73%)
CGC   19.06 (+4.27%)
BABA   257.94 (+2.76%)
TSLA   1,485.00 (+3.79%)
MU   50.39 (+0.68%)
GE   6.11 (+0.66%)
AMD   77.67 (+0.31%)
T   29.62 (+0.14%)
F   6.69 (+1.21%)
ACB   10.42 (+2.26%)
GILD   71.73 (+3.16%)
NFLX   498.62 (+1.99%)
DIS   116.35 (-0.50%)
BAC   24.99 (+0.44%)
BA   162.27 (+2.70%)
S&P 500   0.56 (+5.04%)
DOW   0.56 (+5.04%)
QQQ   269.38 (+1.35%)
AAPL   435.75 (+2.52%)
MSFT   216.54 (+5.62%)
FB   251.96 (-0.67%)
GOOGL   1,482.76 (-0.35%)
AMZN   3,111.89 (-1.67%)
NVDA   440.41 (+3.73%)
CGC   19.06 (+4.27%)
BABA   257.94 (+2.76%)
TSLA   1,485.00 (+3.79%)
MU   50.39 (+0.68%)
GE   6.11 (+0.66%)
AMD   77.67 (+0.31%)
T   29.62 (+0.14%)
F   6.69 (+1.21%)
ACB   10.42 (+2.26%)
GILD   71.73 (+3.16%)
NFLX   498.62 (+1.99%)
DIS   116.35 (-0.50%)
BAC   24.99 (+0.44%)
BA   162.27 (+2.70%)
S&P 500   0.56 (+5.04%)
DOW   0.56 (+5.04%)
QQQ   269.38 (+1.35%)
AAPL   435.75 (+2.52%)
MSFT   216.54 (+5.62%)
FB   251.96 (-0.67%)
GOOGL   1,482.76 (-0.35%)
AMZN   3,111.89 (-1.67%)
NVDA   440.41 (+3.73%)
CGC   19.06 (+4.27%)
BABA   257.94 (+2.76%)
TSLA   1,485.00 (+3.79%)
MU   50.39 (+0.68%)
GE   6.11 (+0.66%)
AMD   77.67 (+0.31%)
T   29.62 (+0.14%)
F   6.69 (+1.21%)
ACB   10.42 (+2.26%)
GILD   71.73 (+3.16%)
NFLX   498.62 (+1.99%)
DIS   116.35 (-0.50%)
BAC   24.99 (+0.44%)
BA   162.27 (+2.70%)
Log in

LON:IDOXIDOX Share Price, Forecast & News

GBX 48.60
-0.30 (-0.61 %)
(As of 07/14/2020)
Add
Compare
Today's Range
48.50
Now: GBX 48.60
49.40
50-Day Range
43.50
MA: GBX 47.91
50.40
52-Week Range
0.48
Now: GBX 48.60
51
Volume342,288 shs
Average Volume1.13 million shs
Market Capitalization£215.42 million
P/E Ratio486.00
Dividend Yield3.80%
BetaN/A
Idox plc, through its subsidiaries, provides software solutions and information services for the management of local government and other organizations worldwide. The company operates through five segments: Public Sector Software, Engineering Information Management, Content, Digital, and Health. It offers tools to manage information and knowledge, documents, content, business processes, and workflow, as well as connects directly with the citizens through the Web; elections management solutions; and decision support content, which include grants and planning policy information, as well as corporate compliance services. The company also provides engineering document control, project collaboration, and facility management applications to companies in industries, such as oil and gas, architecture and construction, mining, utilities, pharmaceuticals, and transportation; funding solutions to corporate, public, and commercial customers; digital consultancy services to public, private, and third sector customers; and solutions to the healthcare market. Idox plc was incorporated in 2000 and is based in Reading, the United Kingdom.
Read More
IDOX logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 1.6Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.95 out of 5 stars


Industry, Sector and Symbol

Industry Technical & System Software
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone-870-3337101

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£69.64 million
Cash FlowGBX 7.34 per share
Book ValueGBX 10.20 per share

Profitability

Miscellaneous

Employees749
Market Cap£215.42 million
Next Earnings DateN/A
OptionableNot Optionable
GBX 48.60
-0.30 (-0.61 %)
(As of 07/14/2020)
30 days | 90 days | 365 days | Advanced Chart

Receive IDOX News and Ratings via Email

Sign-up to receive the latest news and ratings for IDOX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











IDOX (LON:IDOX) Frequently Asked Questions

How has IDOX's stock been impacted by COVID-19 (Coronavirus)?

IDOX's stock was trading at GBX 37 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, IDOX shares have increased by 31.4% and is now trading at GBX 48.60.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of IDOX?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IDOX in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for IDOX
.

How were IDOX's earnings last quarter?

IDOX plc (LON:IDOX) issued its quarterly earnings data on Monday, June, 15th. The company reported ($0.23) earnings per share for the quarter.
View IDOX's earnings history
.

What price target have analysts set for IDOX?

1 brokers have issued 1-year target prices for IDOX's stock. Their forecasts range from GBX 53 to GBX 53. On average, they anticipate IDOX's share price to reach GBX 53 in the next twelve months. This suggests a possible upside of 9.1% from the stock's current price.
View analysts' price targets for IDOX
.

Has IDOX been receiving favorable news coverage?

Press coverage about IDOX stock has trended negative on Monday, InfoTrie Sentiment reports. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. IDOX earned a media sentiment score of -2.9 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the next several days.
View the latest news about IDOX
.

Who are some of IDOX's key competitors?

What other stocks do shareholders of IDOX own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IDOX investors own include Canadian National Railway (CNR), SLM (SLM), Chipotle Mexican Grill (CMG), Kinder Morgan (KMI), LPL Financial (LPLA), OFG Bancorp (OFG), Telford Homes (TEF), ASOS (ASC), Arcontech Group (ARC) and Alliance Pharma (APH).

Who are IDOX's key executives?

IDOX's management team includes the following people:
  • Mr. David J. Meaden, CEO & Director (Age 57)
  • Mr. Robert James Grubb, CFO & Director
  • Ms. Jane Mackie, Exec. (Age 39)

What is IDOX's stock symbol?

IDOX trades on the London Stock Exchange (LON) under the ticker symbol "IDOX."

How do I buy shares of IDOX?

Shares of IDOX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is IDOX's stock price today?

One share of IDOX stock can currently be purchased for approximately GBX 48.60.

How big of a company is IDOX?

IDOX has a market capitalization of £215.42 million and generates £69.64 million in revenue each year. IDOX employs 749 workers across the globe.

What is IDOX's official website?

The official website for IDOX is www.idoxgroup.com.

How can I contact IDOX?

IDOX's mailing address is 2nd Fl, 1310 Waterside, READING, RG7 4SA, United Kingdom. The company can be reached via phone at -870-3337101.

This page was last updated on 8/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.